Cabot Co. (NYSE:CBT) Shares Acquired by Natixis Advisors LLC

Natixis Advisors LLC lifted its position in Cabot Co. (NYSE:CBT - Free Report) by 14.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 116,011 shares of the specialty chemicals company's stock after acquiring an additional 14,740 shares during the quarter. Natixis Advisors LLC owned 0.21% of Cabot worth $12,967,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Oppenheimer Asset Management Inc. lifted its position in shares of Cabot by 2.9% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 43,484 shares of the specialty chemicals company's stock worth $4,860,000 after purchasing an additional 1,244 shares during the period. Aigen Investment Management LP purchased a new stake in Cabot during the third quarter worth $482,000. Entropy Technologies LP bought a new stake in Cabot during the 3rd quarter valued at $701,000. Los Angeles Capital Management LLC increased its holdings in shares of Cabot by 25.0% in the 3rd quarter. Los Angeles Capital Management LLC now owns 23,794 shares of the specialty chemicals company's stock valued at $2,659,000 after acquiring an additional 4,756 shares during the period. Finally, Crossmark Global Holdings Inc. lifted its stake in shares of Cabot by 11.5% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 3,965 shares of the specialty chemicals company's stock worth $443,000 after purchasing an additional 410 shares during the last quarter. 93.18% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have commented on CBT. UBS Group reduced their target price on shares of Cabot from $103.00 to $98.00 and set a "neutral" rating for the company in a report on Tuesday, August 6th. Mizuho boosted their price objective on shares of Cabot from $103.00 to $122.00 and gave the stock an "outperform" rating in a research note on Tuesday, November 5th. Finally, JPMorgan Chase & Co. cut shares of Cabot from a "neutral" rating to an "underweight" rating and set a $105.00 target price for the company. in a research report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $105.00.

Insider Activity

In other news, EVP Jeff Ji Zhu sold 1,201 shares of Cabot stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $106.19, for a total transaction of $127,534.19. Following the completion of the transaction, the executive vice president now directly owns 96,000 shares of the company's stock, valued at $10,194,240. The trade was a 1.24 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Hobart Kalkstein sold 34,759 shares of the stock in a transaction on Monday, November 11th. The stock was sold at an average price of $115.23, for a total transaction of $4,005,279.57. Following the sale, the executive vice president now directly owns 50,627 shares in the company, valued at $5,833,749.21. This trade represents a 40.71 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 93,398 shares of company stock valued at $10,188,968 in the last ninety days. Insiders own 3.07% of the company's stock.

Cabot Stock Performance

Shares of CBT traded up $1.46 during trading hours on Thursday, reaching $108.67. 276,070 shares of the company traded hands, compared to its average volume of 344,610. The company has a quick ratio of 1.36, a current ratio of 2.08 and a debt-to-equity ratio of 0.68. The business has a fifty day moving average price of $110.70 and a 200-day moving average price of $102.55. Cabot Co. has a 12-month low of $70.63 and a 12-month high of $117.46. The stock has a market capitalization of $5.96 billion, a P/E ratio of 16.12, a P/E/G ratio of 0.92 and a beta of 1.20.

Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share for the quarter, missing the consensus estimate of $1.81 by ($0.01). Cabot had a net margin of 9.51% and a return on equity of 26.60%. The firm had revenue of $1 billion for the quarter, compared to analysts' expectations of $1.01 billion. During the same quarter in the previous year, the firm posted $1.65 EPS. The firm's revenue for the quarter was up 3.7% compared to the same quarter last year. Equities analysts anticipate that Cabot Co. will post 7.68 EPS for the current fiscal year.

Cabot Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Shareholders of record on Friday, November 29th will be paid a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.58%. The ex-dividend date is Friday, November 29th. Cabot's payout ratio is 25.52%.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.